125 related articles for article (PubMed ID: 23242569)
1. Survivin expression in medulloblastoma: a possible marker for survival.
Abdel-Aziz A; Mohamed MA; Akl FM; Taha AN
Pathol Oncol Res; 2013 Jul; 19(3):413-9. PubMed ID: 23242569
[TBL] [Abstract][Full Text] [Related]
2. Lack of prognostic significance of survivin in pediatric medulloblastoma.
Faccion RS; Ferreira RM; Grabois MF; Fonseca TC; de Oliveira JA; Maia RC
Pathol Oncol Res; 2011 Dec; 17(4):899-908. PubMed ID: 21681603
[TBL] [Abstract][Full Text] [Related]
3. Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.
Fangusaro JR; Jiang Y; Holloway MP; Caldas H; Singh V; Boué DR; Hayes J; Altura RA
Br J Cancer; 2005 Jan; 92(2):359-65. PubMed ID: 15655550
[TBL] [Abstract][Full Text] [Related]
4. Survivin is a negative prognostic marker in medulloblastoma.
Pizem J; Cört A; Zadravec-Zaletel L; Popovic M
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):422-8. PubMed ID: 16008826
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of survivin splice isoforms in medulloblastomas.
Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.
Bodey B; Bodey V; Siegel SE; Kaiser HE
In Vivo; 2004; 18(6):713-8. PubMed ID: 15646811
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ
Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586
[TBL] [Abstract][Full Text] [Related]
8. Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
Sandén E; Dyberg C; Krona C; Visse E; Carén H; Northcott PA; Kool M; Ståhl N; Persson A; Englund E; Johnsen JI; Siesjö P; Darabi A
J Neurooncol; 2015 May; 123(1):1-13. PubMed ID: 25820321
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of pathologic characteristics and prognosis in different subtypes of adult medulloblastoma].
Zhao F; Zhang J; Wang X; Wang Z; Wang Y; Qu P; Luo L; Liu P
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):169-72. PubMed ID: 24842015
[TBL] [Abstract][Full Text] [Related]
10. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
11. [Expression of KDR in medulloblastoma and its clinical implication].
Cheng H; Mao B; Zhang S; Cheng N
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):369-71. PubMed ID: 12536566
[TBL] [Abstract][Full Text] [Related]
12. Expression of Gli1 and PARP1 in medulloblastoma: an immunohistochemical study of 65 cases.
Pizem J; Popovic M; Cör A
J Neurooncol; 2011 Jul; 103(3):459-67. PubMed ID: 20953661
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of insulin-like growth factor binding protein isoforms in medulloblastoma subtypes and clinical correlation.
Narayan R; Shastry AH; Thota B; Sampath S; Thennarasu K; Arivazhagan A; Santosh V
Pediatr Neurosurg; 2013; 49(6):325-30. PubMed ID: 25427587
[TBL] [Abstract][Full Text] [Related]
15. A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma.
Zhao X; Song T; He Z; Tang L; Zhu Y
Med Oncol; 2010 Sep; 27(3):985-91. PubMed ID: 19806481
[TBL] [Abstract][Full Text] [Related]
16. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients.
Priller M; Pöschl J; Abrão L; von Bueren AO; Cho YJ; Rutkowski S; Kretzschmar HA; Schüller U
Clin Cancer Res; 2011 Nov; 17(21):6791-801. PubMed ID: 21918172
[TBL] [Abstract][Full Text] [Related]
17. Expression of p75NTR in fetal brain and medulloblastomas: evidence of a precursor cell marker and its persistence in neoplasia.
Barnes M; Eberhart CG; Collins R; Tihan T
J Neurooncol; 2009 Apr; 92(2):193-201. PubMed ID: 19066726
[TBL] [Abstract][Full Text] [Related]
18. Neuron-associated class III beta-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: a clinicopathological analysis of 36 cases.
Maraziotis T; Perentes E; Karamitopoulou E; Nakagawa Y; Gessaga EC; Probst A; Frankfurter A
Acta Neuropathol; 1992; 84(4):355-63. PubMed ID: 1441916
[TBL] [Abstract][Full Text] [Related]
19. Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells.
Patil S; Sankpal UT; Hurtado M; Bowman WP; Murray J; Borgmann K; Ghorpade A; Sutphin R; Eslin D; Basha R
Gene; 2019 Jul; 705():67-76. PubMed ID: 30991098
[TBL] [Abstract][Full Text] [Related]
20. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
